- Home
- ERAS vs NMCO Comparison
ERAS vs NMCO Comparison
Compare ERAS & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- NMCO
- Stock Information
- Founded
- ERAS 2018
- NMCO 2019
- Country
- ERAS United States
- NMCO United States
- Employees
- ERAS N/A
- NMCO N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- NMCO Finance/Investors Services
- Sector
- ERAS Health Care
- NMCO Finance
- Exchange
- ERAS Nasdaq
- NMCO Nasdaq
- Market Cap
- ERAS 723.8M
- NMCO 611.9M
- IPO Year
- ERAS 2021
- NMCO N/A
- Fundamental
- Price
- ERAS $1.90
- NMCO $10.83
- Analyst Decision
- ERAS Strong Buy
- NMCO
- Analyst Count
- ERAS 5
- NMCO 0
- Target Price
- ERAS $5.70
- NMCO N/A
- AVG Volume (30 Days)
- ERAS 1.5M
- NMCO 207.6K
- Earning Date
- ERAS 11-12-2024
- NMCO 01-01-0001
- Dividend Yield
- ERAS N/A
- NMCO 5.43%
- EPS Growth
- ERAS N/A
- NMCO N/A
- EPS
- ERAS N/A
- NMCO N/A
- Revenue
- ERAS N/A
- NMCO N/A
- Revenue This Year
- ERAS N/A
- NMCO N/A
- Revenue Next Year
- ERAS N/A
- NMCO N/A
- P/E Ratio
- ERAS N/A
- NMCO N/A
- Revenue Growth
- ERAS N/A
- NMCO N/A
- 52 Week Low
- ERAS $1.64
- NMCO $8.52
- 52 Week High
- ERAS $3.45
- NMCO $11.64
- Technical
- Relative Strength Index (RSI)
- ERAS 29.70
- NMCO 54.34
- Support Level
- ERAS $1.77
- NMCO $10.60
- Resistance Level
- ERAS $2.84
- NMCO $10.82
- Average True Range (ATR)
- ERAS 0.18
- NMCO 0.12
- MACD
- ERAS -0.07
- NMCO 0.04
- Stochastic Oscillator
- ERAS 12.15
- NMCO 86.05
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About NMCO Nuveen Municipal Credit Opportunities Fund
Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.